WWP
NAVB

WR Wealth Planners’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

WR Wealth Planners’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10
Closed – – 1206
2024
Q3 		$0 Hold
10
– – ﹤0.01% 1222
2024
Q2 		$0 Hold
10
– – ﹤0.01% 1233
2024
Q1 		$0 Buy
+10
New – ﹤0.01% 1177

WR Wealth Planners's NAVB Position: Q4 2024 in Review

WR Wealth Planners sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2024, closing a stake of 10 shares.

WR Wealth Planners first reported a position in NAVB in Q1 2024 and held it in 3 quarters. The position peaked at $0 in Q3 2024. 1 fund tracked by Wall St. Rank holds NAVB as of Q4 2024.

  • WR Wealth Planners reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2024 after selling out during the quarter.
  • WR Wealth Planners sold 10 Navidea Biopharmaceuticals Inc. shares in Q4 2024.
  • WR Wealth Planners first reported a position in Navidea Biopharmaceuticals Inc. in Q1 2024 and held it in 3 quarters.
  • WR Wealth Planners's Navidea Biopharmaceuticals Inc. position peaked at $0 in Q3 2024.
  • 1 fund tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.